Prenatal screening for Down's syndrome using inhibin-A as a serum marker

Prenatal Diagnosis

Volumn 16, Issue 2, 1996, Pages 143-153

  Wald, Nicholas J ^a   Densem, James W ^a   George, Lynne ^a   Muttukrishna, Shauthi ^b   Knight, Philip G ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Down's syndrome; Inhibin A; Maternal serum screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN; INHIBIN A;

ACCURACY; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOWN SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL AGE; META ANALYSIS; PRENATAL SCREENING; PRIORITY JOURNAL; TECHNIQUE; ULTRASOUND;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0030027962     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F     Document Type: Article

References (23)

1. Baird, D.T., Smith, K.B. (1993). Inhibin and related peptides in the regulation of reproduction, Oxford Rev. Reprod Biol., 15, 191-232.
2. Canick, J.A., Lambert-Messerlian, G.M., Palomaki, G.E., Schnever, A.L., Tumber, M.B., Knight, G.J., Haddow, J.E. (1994). Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy. Am. J. Hum. Genet., 55, A37.
3. Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level, Br. J. Obstet. Gynaecol., 94, 387-402.
4. Cuckle, H.S., Holding, S., Jones, R. (1994). Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies, Prenat. Diagn., 14, 387-390.
5. Cuckle, H.S., Holding, S., Jones, R., Wallace, E.M., Groome, N.P. (1995). Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies, Prenat. Diagn., 15, 385-392.
6. Groome, N.P., Illingworth, P.J., O'Brian, M., Cooke, I., Ganesan, T.S., McNeilly, A.S. (1994). Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay, Clin. Endocrinol., 40, 717-723.
7. McLachlan, R.I., Healy, D.L., Lutjen, P.J., Findlay, J.K., de Kretser, D.M., Burger, H.G. (1987a). The maternal ovary is not the source of circulating inhibin levels during human pregnancy, Clin. Endocrinol., 27, 663-668.
8. McLachlan, R.I., Healy, D.L., Robertson, D.M., Burger, H.G., de Kretser, D.M. (1987b). Circulating immunoreactive inhibin in the luteal phase and early gestation in women undergoing ovulation induction, Fertil. Steril., 48, 1011-1015.
9. Muttukrishna, S., Fowler, P.A., Groome, N.P., Mitchell, G.G., Robertson, W.R., Knight, P.G. (1994). Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin, Hum. Reprod., 9, 1634-1642.
10. A dimer) during human pregnancy. J. Clin. Endocrinol., 42, 391-397.
11. Office of Population Censuses and Surveys (1985-1990). Birth Statistics, Series FM1, Nos. 11, 12, 15-17, London: HMSO.
12. Petraglia, F., Sawchenko, P., Lim, A.T.W., Rivier, J., Vale, W. (1987). Localization, secretion, and action of inhibin in human placenta. Science, 237, 187-189.
13. Spencer, K., Wood, P.J., Antony, F.W. (1993). Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome, Ann. Clin. Biochem., 30, 219-220.
14. Van Lith, J.M., Pratt, J.J., Beekhuis, J.R., Mantingh, A. (1992). Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome, Prenat. Diagn., 12, 801-806.
15. Wald, N.J., Densem, J.W. (1993). Use of unconjugated oestriol in screening for Down's syndrome, Prenat. Diagn., 13, 1149.
16. Wald, N.J., Cuckle, H.S., Densem, J.W., Nanchahal, K., Royston, P., Chard, T., Haddow, J.E., Knight, GJ., Palomaki, G.E., Canick, J.A. (1988). Maternal serum screening for Down's syndrome in early pregnancy, Br. Med. J., 297, 883-887.
17. Wald, N.J., Cuckle, H.S., Densem, J.W., Kennard, A., Smith, D. (1992). Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br. J. Obstet. Gynaecol., 99, 144-149.
18. Wald, N., Densem, J., Stone, R., Cheng, R. (1993a). The use of free β-hCG in antenatal screening for Down's syndrome, Br. J. Obstet. Gynaecol., 100, 550-557.
19. Wald, N.J., Smith, D., Kennard, A., Palomaki, G.E., Salonen, R., Holzgreve, W., Pejtsik, B., Coombes, E.J., Mancini, G., MacRae, A.R., Wyatt, P., Roberson, J. (1993b). Biparietal diameter and crownrump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome, Br. J. Obstet. Gynaecol., 100, 430-435.
20. Wald, N.J., Densem, J.W., Smith, D., Klee, G.G. (1994). Four-marker serum screening for Down's syndrome. Prenat. Diagn., 14, 707-716.
21. Wallace, E.M., Grant, V.E., Swanston, I.A., McNeilly, A.S., Blundell, G., Ashby, J.P., Groome, N.P. (1995). Second trimester screening for Down's syndrome using inhibin-A, J. Endocrinol., 144, 134.
22. Webley, G., Muttukrishna, S., Groome, N.P., Knight, P.G. (1994). Evidence that endogenous dimeric inhibin enhances progesterone production by human granulosa-lutein cells, J. Reprod. Fertil. Abstr. Ser., 13, 85A.
23. Ying, S.Y. (1988). Inhibins. activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone, Endocrine Rev., 9, 267-293.